Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Diabetes: Daily Aspirin or Other Antiplatelet for Diabetes Patients with Ischemic Vascular Disease (IVD) Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 26 Clinics in the Aspirus health system


The results below represent the care of 518 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ASPIRUS ANTIGO CLINIC
N=194
97.42 %
View Historical Data
ASPIRUS DOCTORS CLINIC
N=203
96.06 %
View Historical Data
ASPIRUS GILMAN CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS KRONENWETTER CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS LAND O LAKES CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS LANGLADE HOSPITAL-BIRNAMWOOD CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS LANGLADE HOSPITAL-ELCHO CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS MEDFORD CLINIC
N=121
95.04 %
View Historical Data
ASPIRUS PEDIATRICS

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS PHILLIPS CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS PRENTICE CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS RHINELANDER CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS RIB LAKE CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS THREE LAKES CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL EDGAR CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL FAMILY HEALTH SPECIALISTS

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL FAMILY MEDICINE CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL FAMILY PHYSICIANS

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL MARATHON CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL MERRILL CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL STEVENS POINT CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WAUSAU HOSPITAL WESTHILL MEDICAL SPECIALISTS

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WESTON CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WITTENBERG CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
ASPIRUS WOODRUFF CLINIC

The number of patients or providers is too small for
purposes of reliably reporting performance
Test Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance

Based on trials involving other secondary prevention therapies, the American College of Cardiology (ACC) and the American Heart Assocation (AHA) recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions. The American Diabetes Association (ADA) supports this recommendation as a secondary prevention strategy for type 1 or type 2 diabetes with a history of cardiovascular disease.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.